Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


22 Items
Title  Creator  Group name  Publishing year 
[Predictive factors assessment of pathological response to neoadjuvant radiotherapy of soft tissue sarcomas] Hanslik et al. EquipeJPP 2023-10-07
Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decision Azria et al. EquipeJPP 2023-05
[From fibrogenesis towards fibrosis: Pathophysiological mechanisms and clinical presentations] Maria et al. EquipeAP Feb 08, 2020
Five-year results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial Bosma et al. EquipeAP Jan 24, 2020
[Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer] Latorzeff et al. EquipeAP Sep 06, 2019
[Treatment of oligometastatic or oligoprogression cancer] Bourgier et al. EquipeAP Sep 05, 2019
[Predictive assays for responses of tumors and normal tissues in radiation oncology] Riou et al. EquipeAP Aug 23, 2019
[Individual modification of the dose, volume and fractionation of breast radiotherapy] Bourgier et al. EquipeJPP 2019-10
The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice Montero-Luis et al. EquipeAP Jun 2019
[The major debate: Micrometastases and breast cancer - To be for nodal irradiation] Bourgier et al. EquipeAP Aug 22, 2018
[Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting] Kammerer et al. EquipeAP Aug 22, 2018
Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy Taourel et al. EquipeAP Dec 2018
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women Corsini et al. EquipeAP Aug 05 2017
[Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?] Lemanski et al. EquipeNB Jun 2015
[Radiosensitivity settings in breast cancer] Lauche et al. EquipeNB Jun 2015
[Radiomics: Definition and clinical development] Bourgier et al. EquipeJC Oct 2015
[Impact of intensity-modulated radiotherapy on node irradiation for breast cancer] Fenoglietto et al. EquipeNB Jun 2015
[Does nodal irradiation (clavicular and internal mammary chains) increase the toxicity of adjuvant breast radiotherapy?] Riou et al. EquipeNB Jun 2015
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Azria et al. EquipeAP Dec 2015
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy Bourgier et al. EquipePC Mar 2015
Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial Bourgier et al. EquipeAP Dec 17, 2015
[Stereotactic body radiation therapy and oligometastases] Bourgier et al. EquipeNB 2014 Jul-Aug
22 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés